Annual Operating Profit
-$18.87 M
-$3.60 M-23.57%
31 December 2023
Summary:
CNS Pharmaceuticals annual operaing income is currently -$18.87 million, with the most recent change of -$3.60 million (-23.57%) on 31 December 2023. During the last 3 years, it has fallen by -$9.41 million (-99.53%). CNSP annual operating profit is now -2039.39% below its all-time high of -$881.80 thousand, reached on 31 December 2018.CNSP Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$5.63 M
-$3.10 M-122.65%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly operating income is currently -$5.63 million, with the most recent change of -$3.10 million (-122.65%) on 30 September 2024. Over the past year, it has dropped by -$1.10 million (-24.15%). CNSP quarterly operating profit is now -3213.07% below its all-time high of -$169.90 thousand, reached on 30 September 2018.CNSP Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$17.08 M
-$1.10 M-6.85%
30 September 2024
Summary:
CNS Pharmaceuticals TTM operating income is currently -$17.08 million, with the most recent change of -$1.10 million (-6.85%) on 30 September 2024. Over the past year, it has increased by +$1.54 million (+8.26%). CNSP TTM operating profit is now -8588.35% below its all-time high of -$196.60 thousand, reached on 30 June 2018.CNSP TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.6% | -24.1% | +8.3% |
| 3 y3 years | -99.5% | -47.6% | -20.0% |
| 5 y5 years | -2039.4% | -705.2% | -1025.3% |
CNSP Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.5% | at low | -122.7% | at low | -27.6% | +9.5% |
| 5 y | 5 years | -2039.4% | at low | -705.2% | at low | -1025.3% | +9.5% |
| alltime | all time | -2039.4% | at low | -3213.1% | at low | -8588.4% | +9.5% |
CNS Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.63 M(+122.7%) | -$17.08 M(+6.9%) |
| June 2024 | - | -$2.53 M(-28.7%) | -$15.99 M(-8.6%) |
| Mar 2024 | - | -$3.54 M(-34.1%) | -$17.48 M(-7.3%) |
| Dec 2023 | -$18.87 M(+23.6%) | -$5.38 M(+18.7%) | -$18.87 M(+1.3%) |
| Sept 2023 | - | -$4.53 M(+12.6%) | -$18.62 M(+6.4%) |
| June 2023 | - | -$4.03 M(-18.3%) | -$17.51 M(+2.7%) |
| Mar 2023 | - | -$4.93 M(-4.1%) | -$17.04 M(+11.6%) |
| Dec 2022 | -$15.27 M(+5.4%) | -$5.13 M(+50.2%) | -$15.27 M(+14.1%) |
| Sept 2022 | - | -$3.42 M(-4.1%) | -$13.38 M(-2.9%) |
| June 2022 | - | -$3.56 M(+13.2%) | -$13.78 M(-1.8%) |
| Mar 2022 | - | -$3.15 M(-3.1%) | -$14.03 M(-3.2%) |
| Dec 2021 | -$14.49 M | -$3.25 M(-14.7%) | -$14.49 M(+1.8%) |
| Sept 2021 | - | -$3.81 M(+0.1%) | -$14.24 M(+14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$3.81 M(+5.6%) | -$12.43 M(+12.1%) |
| Mar 2021 | - | -$3.61 M(+20.3%) | -$11.10 M(+17.4%) |
| Dec 2020 | -$9.45 M(+146.7%) | -$3.00 M(+49.3%) | -$9.45 M(+5.3%) |
| Sept 2020 | - | -$2.01 M(-18.7%) | -$8.98 M(+17.1%) |
| June 2020 | - | -$2.47 M(+25.7%) | -$7.66 M(+36.7%) |
| Mar 2020 | - | -$1.97 M(-22.0%) | -$5.61 M(+46.3%) |
| Dec 2019 | -$3.83 M(+334.7%) | -$2.52 M(+261.0%) | -$3.83 M(+152.5%) |
| Sept 2019 | - | -$699.10 K(+68.4%) | -$1.52 M(+53.5%) |
| June 2019 | - | -$415.10 K(+112.8%) | -$988.70 K(+28.4%) |
| Mar 2019 | - | -$195.10 K(-6.5%) | -$770.20 K(+33.9%) |
| Dec 2018 | -$881.80 K | -$208.60 K(+22.8%) | -$575.10 K(+56.9%) |
| Sept 2018 | - | -$169.90 K(-13.6%) | -$366.50 K(+86.4%) |
| June 2018 | - | -$196.60 K | -$196.60 K |
FAQ
- What is CNS Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual operating profit year-on-year change?
- What is CNS Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly operating profit year-on-year change?
- What is CNS Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals TTM operating profit year-on-year change?
What is CNS Pharmaceuticals annual operaing income?
The current annual operating profit of CNSP is -$18.87 M
What is the all time high annual operating profit for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual operaing income is -$881.80 K
What is CNS Pharmaceuticals annual operating profit year-on-year change?
Over the past year, CNSP annual operaing income has changed by -$3.60 M (-23.57%)
What is CNS Pharmaceuticals quarterly operating income?
The current quarterly operating profit of CNSP is -$5.63 M
What is the all time high quarterly operating profit for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly operating income is -$169.90 K
What is CNS Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, CNSP quarterly operating income has changed by -$1.10 M (-24.15%)
What is CNS Pharmaceuticals TTM operating income?
The current TTM operating profit of CNSP is -$17.08 M
What is the all time high TTM operating profit for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high TTM operating income is -$196.60 K
What is CNS Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, CNSP TTM operating income has changed by +$1.54 M (+8.26%)